Evidence map›Paper›PMID 40032849›Full record

ArticleCell death & disease2025

Transcription factor ONECUT3 regulates HDAC6/HIF-1α activity to promote the Warburg effect and tumor growth in colorectal cancer.

Ruixue Huo, Weihan Li, Hao Wu, Kexin He, Hao Wang, Shan Zhang, Shu-Heng Jiang, Rongkun Li, Junli Xue

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Current research on the role of HIF in intervertebral disc degeneration.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruixue Huo *Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Weihan Li *Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Hao Wu *Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Kexin He *Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Hao WangDepartment of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Shan ZhangState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China.
Shu-Heng JiangState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China. shjiang@shsci.org.ORCID http://orcid.org/0000-0001-8516-6234
Rongkun LiChest Oncology Department, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, P.R. China. jiqimaoakun@163.com.
Junli XueDepartment of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P.R. China. 1310666xuejunli@tongji.edu.cn.ORCID http://orcid.org/0000-0002-0564-5284

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82260562, 82372922
6 · The paper itself

Abstract

The Warburg effect, also known as aerobic glycolysis, plays a crucial role in the onset and progression of colorectal cancer (CRC), although its mechanism remains unclear. In this study, bioinformatics analysis of public databases combined with validation using clinical specimens identified the transcription factor ONECUT3 as a key regulator related to the Warburg effect in CRC. Functionally, silencing ONECUT3 reverses the Warburg effect and suppresses tumor growth. Importantly, ONECUT3 promotes tumor growth in a glycolysis-dependent manner through hypoxia-inducible factor 1α (HIF-1α). Mechanistically, ONECUT3 does not directly regulate the expression of HIF-1α but instead inhibits its acetylation via histone deacetylase 6 (HDAC6). This deacetylation enhances the transcriptional activity of HIF-1α, ultimately upregulating multiple glycolysis-related genes downstream of HIF-1α, thereby driving the Warburg effect and facilitating tumor growth in CRC. These findings reveal a novel mechanism by which ONECUT3 regulates the Warburg effect in CRC and suggest that targeting ONECUT3 may offer a promising therapeutic strategy for CRC.

Indexed as

Colorectal NeoplasmsHistone Deacetylase 6Hypoxia-Inducible Factor 1, alpha SubunitWarburg Effect, OncologicAcetylationAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGlycolysisHCT116 CellsHumansMiceMice, Inbred BALB CMice, NudeHDAC6 protein, humanHIF1A protein, humanHistone Deacetylase 6Hypoxia-Inducible Factor 1, alpha Subunit

Identifiers

PMID40032849
PMCPMC11876336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.